Guidant

...earnings since it bought Guidant in April 2006. It looks like it'll finally have one this year, but owning Guidant will now cost the company nearly all of what has been earned so far this year. For the full year, it's expected to wipe out...

In this article: NYSE, Boston Scientific, Abbott Labs, Johnson & Johnson, Pfizer, Fiscal year, Revenue, Eli Lilly, and Food and Drug Administration

...and economic growth. Boston Scientific agreed to pay $296 million to settle a U.S. Justice Department investigation into its Guidant unit's handling of heart devices and restated third-quarter results to show a loss. Guidant will...

In this article: Boston Scientific, Unemployment, New York Mercantile Exchange, U.S. Food and Drug Administration, and U.S. Justice Department

...and Human Services requesting information about contributions made by the company's cardiac rhythm management division - the former Guidant Corp. - to charities with ties to doctors or their families. Such contributions could pose a conflict...

In this article: Boston Scientific Corp., Guidant Corp., US Department Of Justice, New York, and Business operations

* Reaches agreement with U.S. DOJ over Guidant advisories * To pay $296 million as part of deal * Will record Q3 charge of $294 million * Sees 2009 EPS of 75-79 cents, excluding items * Shares rise 1.2 pct (Adds HHS subpoena,...

In this article: Boston Scientific, HHS, Boston, U.S. Department of Justice, Misdemeanor, Office of Inspector General, and New York Stock Exchange

...device maker Boston Scientific says it will pay $296 million to settle a Department of Justice investigation into the company's Guidant unit. The investigation involved product advisories issued by Guidant in 2005, a year before Boston...

In this article: Boston Scientific, Misdemeanor, U.S. Food and Drug Administration, Department of Justice, and Natick, Mass.

...has agreed in principle to settle an investigation with the Department of Justice for $296 million. The probe focused on the former Guidant Corp.'s 2005 warnings on its Contak Renewal and Ventak Prizm medical device products. Boston Scientific...

In this article: Boston Scientific Corp., DOJ, Misdemeanor, MarketWatch, Boston, and U.S.

...by the U.S. Attorney's Office in Minneapolis into alleged violations of the Food, Drug, and Cosmetic Act by Guidant. Under the terms of the agreement, Guidant will plead to two misdemeanor charges related to failure to include information in...

In this article: Boston Scientific, Tax, DOJ, Amortization, Intangible asset, FDA, and Misdemeanor

...Manager and was promoted to his current role of Director of Finance in November 2006. Before joining Brightpoint, he worked for Guidant Corporation as a Senior Financial Analyst and prior to that he spent five years in public accounting...

In this article: Brightpoint, SEC, Revenue, University of Notre Dame, Indiana State University, Ernst & Young, Guidant Corporation, and Africa

...on a heart that remained beating. The technique, involving mechanical heart stabilizers manufactured by companies such as Medtronic Inc and Guidant Corporation, owned by Boston Scientific, is used in about 20 percent of U.S. heart bypass...

In this article: Surgery, University of Colorado Denver, Guidant Corporation, Boston Scientific, Medtronic Inc, and University Medical Center